News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The FDA is proposing to limit annual COVID-19 ... by Novavax Inc. Vaccine manufacturers have said that because COVID vaccines change annually to target specific strains of the virus, the ...
to explain why the changes were made and what they mean for the general public. Why did the FDA diverge from past practice? Until the May 20 announcement, getting a yearly COVID-19 vaccine was ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback